Hematopoietic engraftment of XLA bone marrow CD34+ cells in NOG/SCID mice-Reference-Cited by-同舟云学术

Hematopoietic engraftment of XLA bone marrow CD34+ cells in NOG/SCID mice

Published:2009-01 Issue:2 Volume:11 Page:198-205
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Moreau Thomas,Moreau Thomas,Bardin Florence,Barlogis Vincent,Deist Françoise Le,Moreau Thomas,Bardin Florence,Barlogis Vincent,Deist Françoise Le,Chabannon Christian,Tonnelle Cécile

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference28 articles.

1. X-linked agammaglobulinemia: report on a United States registry of 201 patients;Winkelstein;Medicine (Baltimore),2006

2. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases;Vetrie;Nature.,1993

3. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia;Tsukada;Cell.,1993

4. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway;Nomura;Blood.,2000

5. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children;Noordzij;Pediatr Res.,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia;Journal of Allergy and Clinical Immunology;2024-07

2. Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector;Molecular Therapy - Methods & Clinical Development;2021-03